Brief: Mauna Kea, Tasly Pharmaceutical Announce Incorporation Of JV In China
Nov 7 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES AND TASLY PHARMACEUTICAL ANNOUNCE
THE
INCORPORATION OF JOINT VENTURE IN CHINA
* TASLY MAUNA KEA MEDICAL ENGINEERING TECHNOLOGY CO. LTD
WILL
EXPAND REACH OF CELLVIZIO IN CHINA AND LAUNCH A DEDICATED
PLATFORM FOR NEUROSURGICAL APPLICATIONS WORLDWIDE
Source text for Eikon: ID:nBw60QVHXa
Further company coverage: MKEA.PA 600535.SS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus